Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
2.
Diabetes Metab Syndr ; 15(3): 1001-1006, 2021.
Article in English | MEDLINE | ID: covidwho-1228014

ABSTRACT

BACKGROUND AND AIMS: Reinfection is gradually being recognised after symptomatic or asymptomatic COVID-19 infection. We try to elucidate various explanations behind COVID-19 reinfection and suggest possible strategies to counteract this threat. METHODS: We carried out a comprehensive review of the literature using suitable keywords such as 'COVID-19', 'Pandemics', 'Reinfection', 'Vaccines' and 'India' on the search engines of PubMed, SCOPUS, Google Scholar and Research Gate in March 2021 and first half of April 2021 during the current COVID-19 pandemic. Epidemiology, risk factors and trends of reinfection were assessed. RESULTS: A multitude of factors have been associated with rising incidence of COVID-19 reinfection in India and across the world. Emergence of 'Variants of Concern (VOC)', pandemic fatigue and disregard of infection prevention strategies appear to be the most obvious reasons. CONCLUSIONS: COVID-19 reinfection is an emerging concern amongst the worldwide population with newer mutant strains demonstrating increasing transmissibility and responsible for continuing waves of the pandemic. COVID Appropriate Behaviour (CAB), improvised vaccines and enhanced vaccination drives are necessary to mitigate global threat.


Subject(s)
COVID-19/epidemiology , COVID-19/etiology , Reinfection , COVID-19/therapy , COVID-19 Vaccines/therapeutic use , Humans , Incidence , India/epidemiology , Pandemics , Reinfection/epidemiology , Reinfection/etiology , Reinfection/therapy , Risk Factors , SARS-CoV-2/immunology , SARS-CoV-2/physiology
4.
Ear Nose Throat J ; 100(2_suppl): 180S-181S, 2021 Apr.
Article in English | MEDLINE | ID: covidwho-967243

ABSTRACT

COVID-19, an ongoing world pandemic, is caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). Many organizations have recognized that COVID-19 patients may have sudden loss of smell or taste and have included these symptoms in their diagnostic guidelines. However, the occurrence of anosmia and dysgeusia in COVID-19 reinfection is yet to be ascertained.


Subject(s)
Anosmia/physiopathology , COVID-19/physiopathology , Reinfection/physiopathology , Anosmia/etiology , COVID-19/complications , COVID-19/diagnosis , COVID-19 Nucleic Acid Testing , Female , Humans , Reinfection/diagnosis , Reinfection/etiology , SARS-CoV-2 , Severity of Illness Index , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL